Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
108
Number of overlapping holdings
56.3%
% of IBB's 212 holdings also in XBI
79.4%
% of XBI's 136 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 9.9% | 3.0% | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 8.0% | 2.6% | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% | 2.5% | 2.5% |
|
AMGEN INC | 6.9% | 2.2% | 2.2% |
|
BIOGEN IDEC INC | 2.2% | 2.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to XBI
|
GILEAD SCIENCES INC | 6.9% |
|
VERTEX PHARMACEUTICALS INC | 5.4% |
|
AMGEN INC | 4.8% |
|
IQVIA HOLDINGS INC | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.6% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
 |
BIONTECH SE SPONSORED ADR | 2.5% |
|
ILLUMINA INC | 2.3% |
|
WATERS CORP | 2.3% |
IBB Underweight Relative to XBI
|
EXACT SCIENCES CORP | -2.5% |
|
ABBVIE INC | -2.4% |
|
VIKING THERAPEUTICS, INC. | -1.9% |
|
ADVENTRX PHARMACEUTICALS INC | -1.8% |
|
TG THERAPEUTICS INC | -1.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.6% |
|
INCYTE CORP | -1.6% |
|
NATERA INC | -1.6% |
|
SAREPTA THERAPEUTICS INC | -1.5% |
|
NEUROCRINE BIOSCIENCES INC | -1.5% |